Metabolic
Semaglutide
GLP-1 receptor agonist (Wegovy, Ozempic, Rybelsus). FDA-approved for type 2 diabetes, chronic weight management, and cardiovascular risk reduction in obesity. STEP-1 mean weight loss 14.9% at 68 weeks; SELECT 20% MACE reduction in adults without diabetes.
Reviewed by Marko Maal, MSc Pharmacy · University of Tartu · Pharmaceutical sciences — drug sourcing, formulation, regulatory review · Reviewed May 6, 2026
Reviewed for clinical and pharmacological accuracy by Marko Maal, MSc Pharmacy.
Common doses
| Indication | Route | Dose | Duration | Evidence |
|---|---|---|---|---|
| Type 2 diabetes | SC injection (Ozempic) | 0.25 mg → titrate to 0.5–2 mg weekly | Indefinite | Tier 1 |
| Chronic weight management | SC injection (Wegovy) | 0.25 mg → titrate to 2.4 mg weekly | Indefinite (relapse on cessation) | Tier 1 |
| Type 2 diabetes (oral) | Oral (Rybelsus) | 3 mg → 7 mg or 14 mg daily | Indefinite | Tier 1 |
What the community reports — Semaglutide
distilled from 13 Reddit postsUsers report weight loss of 10–25 lbs over months at doses 0.25–2.4 mg weekly; some develop tolerance requiring dose escalation or medication switching.
- Reported dose
- 0.25–2.4 mg weekly
- Route
- subcutaneous injection
- Frequency
- weekly
- Side effects
- nausea, vomiting, diarrhea, constipation, lightheadedness, weakness, bloating, gas
Ask about Semaglutide
Get an answer from our reviewed articles and community reports, with links to the sources. Not medical advice.
Overview
Semaglutide is the most commercially significant peptide therapy of the modern era. Approved by the FDA in 2017 as Ozempic for type 2 diabetes, again in 2021 as Wegovy for chronic weight management, again in 2019 as Rybelsus for oral diabetes treatment, and most recently in 2023–2025 for cardiovascular risk reduction, chronic kidney disease, and MASH (fatty liver disease). It is the molecule responsible for the cultural and commercial earthquake around GLP-1 medications — Novo Nordisk briefly became Europe's most valuable company on the strength of its semaglutide portfolio.
Mechanistically it is a long-acting GLP-1 receptor agonist: a 31-amino-acid synthetic peptide engineered with two key modifications from the natural human GLP-1 hormone. First, an alpha-aminoisobutyric acid substitution at position 8 protects against degradation by the dipeptidyl peptidase-4 enzyme that normally inactivates GLP-1 within minutes. Second, a fatty acid side chain on a lysine residue allows reversible binding to albumin in plasma, dramatically extending half-life. Together these modifications turn a peptide hormone with a 2-minute half-life into a drug with a 7-day half-life suitable for once-weekly dosing.
How it works
Evidence tier: 2 — mechanism documented in published pharmacology literature.
GLP-1 is an incretin hormone naturally released by L-cells in the small intestine after eating. Its physiological role is to enhance glucose-dependent insulin secretion, suppress glucagon, slow gastric emptying, and signal satiety to the brain. Semaglutide mimics this signal but at a sustained, supraphysiologic level.
The clinical effects unpack into several distinct mechanisms:
- Pancreatic insulin enhancement. Semaglutide stimulates beta cells to release insulin in response to glucose — but only when blood glucose is elevated. This glucose-dependence is why it rarely causes hypoglycemia on its own, in contrast to insulin or sulfonylureas.
- Glucagon suppression. Reduces hepatic glucose output during the postprandial period.
- Slowed gastric emptying. Food remains in the stomach longer, contributing to increased satiety duration. This effect is also responsible for most GI side effects.
- Central appetite suppression. GLP-1 receptors in the hypothalamus and brainstem (area postrema, nucleus tractus solitarius) modulate hunger signaling. The 15–20% weight loss seen with semaglutide reflects sustained reduction in caloric intake driven by genuine appetite suppression rather than willpower.
- Cardiovascular and renal benefits. Independent of weight loss, semaglutide produces measurable reductions in major adverse cardiac events (20% in SELECT) and slows progression of diabetic kidney disease (FLOW trial).
What the evidence actually shows
Evidence tier: 2 — references summarized in the body; see Trial readouts section below for primary-source detail.
Semaglutide has the strongest evidence base of any peptide therapy currently in use:
- STEP 1 (2021). Weight management RCT, n=1,961 adults with obesity. 14.9% mean weight loss over 68 weeks vs 2.4% placebo. Tier 1.
- STEP 2 (2021). Adults with overweight/obesity AND type 2 diabetes. 9.6% weight loss vs 3.4% placebo. Tier 1.
- STEP 3 / 4 / 5. Various populations and intensifications; consistent 12–18% weight loss range. Tier 1.
- SELECT (2023). Cardiovascular outcomes trial, n=17,604 with cardiovascular disease but without diabetes. 20% reduction in major adverse cardiac events. Tier 1.
- FLOW (2024). Renal outcomes trial in T2D + CKD. Significant reduction in kidney disease progression. Tier 1.
- SURPASS comparisons. Tirzepatide outperformed semaglutide in head-to-head trials; semaglutide remains the GLP-1 baseline.
By any reasonable standard this is a well-validated drug across multiple indications.
Reported benefits
In published trials and clinical practice:
- 14–20% body weight reduction over 12–18 months at full dose.
- Substantial improvement in HbA1c (1.5–2.0% reduction in T2D).
- 20% reduction in major adverse cardiac events (SELECT, in patients with established cardiovascular disease).
- Slowed progression of diabetic kidney disease.
- Reductions in liver fat and improvement in MASH histology.
- Emerging evidence in obstructive sleep apnea (where tirzepatide has formal approval), Alzheimer's disease, and substance-use disorders. Trials ongoing.
Risks and reported side effects
Evidence tier: 3 — clinical case-series + animal-model adverse-event data; magnitude varies by molecule.
Most common (>10% of patients):
- Nausea, vomiting, diarrhea, constipation — concentrated during titration. About 5–10% of patients discontinue due to GI intolerance.
- Reduced appetite (the desired effect, but uncomfortable for some).
Less common but clinically important:
- Acute pancreatitis — rare but real. Discontinue if suspected.
- Acute kidney injury, usually in the context of severe vomiting or diarrhea causing dehydration.
- Gallbladder disease — modest increased risk.
- Diabetic retinopathy progression in some T2D patients with pre-existing retinopathy.
- Possible association with thyroid C-cell tumors based on rodent data (black-box warning); not clearly demonstrated in human cohorts but contraindicated in personal/family history of medullary thyroid carcinoma or MEN 2.
The discontinuation reality:
- Stopping semaglutide typically results in significant weight regain — published data shows roughly two-thirds of weight loss is regained within a year of discontinuation. This is not a "willpower failure"; it is the predictable physiology of an appetite-suppressing drug being withdrawn.
Practical considerations
Evidence tier: 5 — community-evolved dose-range guidance; not RCT-derived.
- Branded vs compounded. FDA-approved branded semaglutide (Wegovy, Ozempic, Rybelsus) costs $900–1,350/month without insurance. Compounded semaglutide from licensed pharmacies — operating in a legally contested zone — typically costs $200–500/month. The legal landscape is actively shifting; verify status.
- Dosing. Standard weekly titration: 0.25 mg → 0.5 → 1.0 → 1.7 → 2.4 mg. Most patients reach maximal benefit at 1.7–2.4 mg. Some clinicians use lower long-term maintenance doses.
- Injection technique. Subcutaneous, abdomen or thigh. Pen devices make this trivial.
- GI tolerability. Slow titration and dietary changes (smaller portions, lower fat) substantially reduce nausea.
- Discontinuation planning. If stopping, expect weight regain. Some clinicians transition to lower maintenance doses rather than full discontinuation.
Where to go from here
For the head-to-head comparison with tirzepatide, see the comparison page (forthcoming). For oral semaglutide options including Rybelsus, see the supporting article on oral GLP-1s. For the broader Weight Loss pillar including AOD-9604 and other secondary peptides, see the goal-based hub.
For an endocrinologist or obesity-medicine clinician interested in becoming a Medical Reviewer for our Weight Loss cluster content, see the Medical Review Process page.
Related on Peptide Story
- Weight Loss pillar — GLP-1 receptor agonists
- Semaglutide vs Tirzepatide — head-to-head
- Tapering off GLP-1s without rebound
References
Limitations · Who should NOT use this
Common GI side effects (nausea, vomiting, diarrhea) — most pronounced during titration. Black-box warning for thyroid C-cell tumors based on rodent data; contraindicated in personal or family history of medullary thyroid carcinoma or MEN 2. Risk of acute pancreatitis. Discontinuation typically results in significant weight regain. Avoid in pregnancy. Cost without insurance is $900–1,350/month for branded versions.
Regulatory notes
FDA-approved for type 2 diabetes (Ozempic, 2017), chronic weight management (Wegovy, 2021), cardiovascular risk reduction (2024), chronic kidney disease (2025), and MASH/fatty liver disease (2025). Compounded versions exist in a legally contested zone — Novo Nordisk has actively pursued compounding pharmacies under the 'essentially a copy' doctrine since shortages ended.
Verify what's actually in your Semaglutide vial
Gray-market peptide vials vary widely on identity, purity, and labeled concentration. Finnrick is an independent testing platform that ships consumer-submitted samples to commercial labs and publishes every result in a free public database. Vendors cannot pay for placement or to suppress a result. We don't operate Finnrick — we link to it because post-purchase verification is the right complement to pre-purchase clinical evidence.
Finnrick is independent; we receive no compensation for this link. US-resident free testing as of May 2026.
Where to buy
Semaglutide — cheapest verified vendors
| Vendor | Product | Size | Price | Price / mg | Trust | |
|---|---|---|---|---|---|---|
| Reta Peptide | Semaglutide 100mg | 100 mg vial | $65.00 | $0.65/mg | 40 | Buy |
| Peptidology | Semaglutide 30mg | 30 mg vial | $40.00 | $1.33/mg | 40 | Buy |
| Skye Peptides | Semaglutide 24mg | 24 mg vial | $99.00 | $4.13/mg | 40 | Price n/a |
| Prime Peptides | Semaglutide 15mg | 15 mg vial | $70.00 | $4.67/mg | 40 | Buy |
| Peptide Crafters | Semaglutide 20mg | 20 mg vial | $150.00 | $7.50/mg | 40 | Price n/a |
Prices refreshed 14 hours ago. Links may be affiliate links; how are trust scores calculated?
See all 31 vendors for Semaglutide →Sources
More on Semaglutide
What is the peptide community actually talking about, and what does the discussion data show?
We analyzed 2,271 peptide-related Reddit posts. GLP-1s (tirzepatide, retatrutide, semaglutide) dominate ~59% of mentions. The most common topic isn't results — it's dosing & titration (44% of posts), followed by sourcing and side effects. This is community-signal data, not clinical evidence.
What is tirzepatide, how well does it work, and how does it compare to semaglutide?
Tirzepatide is a once-weekly dual GIP/GLP-1 receptor agonist (Mounjaro for diabetes, Zepbound for obesity) that delivers the largest average weight loss of any approved drug — around 20%+ at the top dose — and beat semaglutide head-to-head. The trade-off is GI side effects, a careful titration, and class cautions that apply in full.
How do GLP-1s affect women specifically — PCOS, fertility, and contraception?
GLP-1s are unusually well-studied in women. They improve weight, insulin resistance, and often menstrual regularity in PCOS; they can restore ovulation (so unplanned pregnancy is a real risk); and they carry a hard pre-conception stop because of their long washout. They are not a fertility drug — the fertility effect is a downstream consequence of weight and metabolic improvement.
What was the peptide community discussing from 14 to 20 September 2026, and how much of it holds up?
BPC-157 took over the week: mentions rose 44%, and the biggest post of the week listed five injuries it healed — a severed Achilles, a crushed spinal cord, a knee ligament, an eyeball, a section of bone. All five trace to real published studies. Four are rats, one is rabbits, none is human, and the post doesn't say so. More seriously, a large account told its audience dihexa 'has good humans safety data' — it has none, and the three papers establishing its proposed mechanism were retracted in April 2025 for image manipulation. Meanwhile the first adequately powered BPC-157 trial, with an MRI endpoint, quietly started recruiting.
What side effects do GLP-1s cause, and how do I manage them safely?
Most GLP-1 side effects are gastrointestinal — nausea, constipation, reflux — and dose-related, which means slow titration and a few diet changes manage the majority. A modest resting heart-rate increase is a known class effect. Most effects ease with time; a handful are red flags that mean stop and seek care.
What is semaglutide, how well does it work, and how does it compare to tirzepatide?
Semaglutide is the most established GLP-1 receptor agonist — Ozempic and Rybelsus for diabetes, Wegovy for obesity — with the deepest evidence base, including the landmark SELECT cardiovascular trial. It delivers roughly 15% average weight loss, less than tirzepatide head-to-head, but leads on proven heart-protection, track record, and an oral option.
Oral semaglutide vs injectable semaglutide
Same molecule, different delivery, very different bioavailability. Injectable semaglutide (Wegovy 1.0-2.4 mg weekly) achieves ~80% bioavailability and reliably produces 13-15% weight loss. Oral semaglutide (Rybelsus 7-14 mg daily) uses a SNAC absorption-enhancer carrier but still delivers only ~1% bioavailability, meaning the daily oral dose is roughly 30-100x the weekly injection equivalent. Real-world weight loss on Rybelsus is typically 4-8% — about half of injectable. The fasting-and-water-restriction protocol is also onerous. Choose oral for needle aversion or strong pill preference; injectable for maximum efficacy.
Semaglutide vs Tirzepatide
Tirzepatide produces ~50% more weight loss in head-to-head SURMOUNT-5 (20.2% vs 13.7% mean total body weight). Semaglutide has the cardiovascular outcomes trial (SELECT) showing 20% MACE reduction. Tirzepatide has the OSA indication (Zepbound). Both are FDA-approved. Choice depends on indication — CV protection favors semaglutide, maximum weight loss favors tirzepatide.
What Reddit users report — Semaglutide
Best-rated real posts mentioning Semaglutide, summarized with a short quote in the poster’s own words. Of these: 1 worked · 4 mixed · 1 didn't work. Anecdotal community signal — not evidence, not medical advice, and not endorsement.
- ✓ Workedr/Retatrutide
Poster lost 18 lbs on retatrutide over 10 weeks with gradual titration to 2 mg. Brother gained 10 lbs on 5 mg after 8 weeks with no appetite suppression, despite previous success with semaglutide.
— u/GreenAd1071 · read on Reddit ↗ - ✗ Didn't workr/Semaglutide
User switched from semaglutide to tirzepatide after a medication break. After 3 months at 7.5mg tirzepatide, they experienced minimal weight loss progress despite strict diet and exercise.
“Switched to tirz and it has been 3 months so far, I am up to the 7.5mg dose and have seen very little progress.”
— u/JackBrown82q · read on Reddit ↗ - ~ Mixedr/Mounjaro
User switched from Wegovy to Mounjaro (tirzepatide, not semaglutide) after 2 years. Experienced severe nausea and weakness starting around week 5-6, unable to keep food down for 24+ hours.
— u/No-Football2902 · read on Reddit ↗ - ~ Mixedr/Retatrutide
User lost 60 lbs on Wegovy, gained it back after stopping, then switched to Retaratide at 12mg with only 20 lbs lost and perceived plateau despite reduced appetite.
— u/singletb · read on Reddit ↗ - ~ Mixedr/Mounjaro
User lost 10 kg initially on Wegovy but hit a plateau, experienced fatigue, and saw no appetite suppression or weight loss on a second course after weight regain.
“This time, however, I hardly noticed any appetite suppression or weight loss, even though I was following what I believed to be a calorie deficit.”
— u/DizzyMess6918 · read on Reddit ↗ - ~ Mixedr/Semaglutide
User restarted Wegovy after 7-month break from Tirzepatide. Experienced weight gain in first 2 weeks, now combining it with intermittent fasting.
“The first 2 weeks had zero weight loss, in fact, I gained.”
— u/Terrible-Pipe9830 · read on Reddit ↗
Posts are pulled from public Reddit threads and summarized for context. Individual experiences vary widely and don’t predict your own results. Always consult a qualified clinician.
Community signal — Semaglutide
Recent posts and videos mentioning Semaglutide from the cron-ingested Reddit + X pipelines and the curated /experts directory. Not endorsement — directional context only.
- r/Peptides· u/No-Tackle9025 · 17m ago
Retatrutide - dieting on ez mode
So I’ve struggled with my weight my whole life max weight 280. Unfortunately after hs and when organized sports ended for me that’s where things went off the rails. I was able to keep a somewhat healthy body in hs while still being heavy, tons of muscle and youth etc. I ballooned up to over 280 over a few years and got extremely lazy, I decided to make a change. This was back in 2015-16. I decided to make a change and lost over 100 lbs but the struggle was immense. I maintained a deficit and lost the weight fast ~1 year, but the mental fortitude and anguish it took on me was immense. Once reaching goal I thought it was over - WRONG. Slowly but surely I gained the weight back over the next 5 years. 2021 I was sitting back at around 280 - again. Mission failed lol. So what’d I do I lost the weight again and again experienced the mental anguish that is losing weight and maintaining a large deficit. During this time I remember semaglutide beginning to become mainstream and heard success and horror stories and thought, I don’t need that to lose the weight or want the side effects, so I powered through lost the weight. Fast forward to August 2025 where am I? Creeping up to 280 again, 265. When I learn about Reta, do a ton of research and learn everything I can about it. Seems too good to be true, sounded much better than its predecessors. I make the plunge. I follow the dosing protocol in the studies for the most part, maybe moving up a week early here and there because it was so well tolerated. The effect was immediate, I must have been prediabetic because the very next day I felt different, I felt better more alert. I attribute this to it correcting my blood sugar. I lost an extreme amount of weight the first 30 days with little to no side effects. I was no longer hungry and even when I was I couldn’t eat enough to gain weight. My experience dieting and maintaining a deficit really accelerated the weight loss. Weighing everything I ate and tracking it became a breeze it was no longer a chore and a torture to do. In fact it was hard to eat enough calories, I experienced anxiety more about not being able to eat enough than the anguish of wanting to eat more to be satisfied! I went from 265 - 200 in 5 months. And the entire time I felt full and completely satisfied with food. The entire time I maintained a large deficit and really it felt normal and at no time did I feel like I was dieting. I came off for a bit and wanted to try tirz so I did and tirz wasn’t for me, not nearly as effective for me. Coming off glps I definitely gained 10 lbs, 3 months ago I hop back on Reta at 210. At this point im well glp adapted I titrate faster than trials but experience essentially no negative side effects no nausea or even constipation. Slowed gastric emptying sure but not constipation. The only side effect I experience without fail with Reta is around 6 mg I get that slight sunburn like feeling of skin sensitivity and it builds for a month then subsides over the next month. Didn’t bother me much. Oh and Anhedonia is apparent, it doesn’t bother me, it’s just noticeable. I don’t see the need to seek out pleasure seeking behaviors as much as I used to, alcohol, games, YouTube, all became less of my life. I’d start playing chess in my phone or poker and would be done quickly, lose a game of chess or an insignificant poker hand for a dollar, immediately I’m done playing. It just wasn’t “doing it” for me anymore. So now in the 3 months back in I’m down to 180 and in better shape then I can ever really remember being in and happier than worms in pig shit! Made it all the way to 12 mg and am titrating down to 2-4. Probably to stay there forever being so damn cheap. Or atleast a very long time so that I can better ingrain a normal eating pattern into my brain so I don’t gain it all back again. No matter what happens I’ll know Reta will be there if I do decide to try coming off again. I just don’t see the point of coming off. I feel completely normal and
- r/Mounjaro· u/Ok_Contribution_47 · 21h ago
I took a selfie every month on this journey
I took a selfie every month on this journey
- r/Mounjaro· u/Life_Economist1992 · 1d ago
My Journey
My Journey
- r/Mounjaro· u/Firm_Economy_5132 · 1d ago
My 2cents after losing 40 lbs
My 2cents after losing 40 lbs
- r/Mounjaro· u/zoszka91 · 2d ago
Do you still eat normal carbs on Mounjaro / GLP-1s?
Do you still eat normal carbs on Mounjaro / GLP-1s?
- r/Mounjaro· u/Sufficient_Candle165 · 2d ago
Mounjaro and tiny hives
Mounjaro and tiny hives
- r/Mounjaro· u/gonewildecat · 2d ago
Nausea question
Nausea question
- r/Mounjaro· u/Sparkle6891 · 2d ago
Exhaustion
Exhaustion
- r/Mounjaro· u/agirlontheroad · 2d ago
Making the switch
Making the switch
- r/Mounjaro· u/Background_Heat2636 · 3d ago
Switching to monjauro from wegovy. Personal experiences
Switching to monjauro from wegovy. Personal experiences
- r/Mounjaro· u/Accomplished-Fail-31 · 3d ago
Mounjaro Side Effects
Mounjaro Side Effects
- r/Mounjaro· u/Healing_Spirit4 · 4d ago
Not losing weight?
Not losing weight?
- r/Mounjaro· u/Smart-Glass2089 · 4d ago
My first dose
My first dose
- r/Mounjaro· u/joe3000s · 5d ago
Lilly's Zepbound (tirzepatide 10 mg and 15 mg) was associated with more weight loss than Wegovy HD (semaglutide injection 7.2 mg) in a new indirect treatment comparison
Lilly's Zepbound (tirzepatide 10 mg and 15 mg) was associated with more weight loss than Wegovy HD (semaglutide injection 7.2 mg) in a new indirect treatment comparison
- r/Mounjaro· u/PhilosopherMoist7737 · 6d ago
Mounjaro for Life
Mounjaro for Life
- r/Mounjaro· u/CBotVLC · 8d ago
Losing hope to return to myself
Losing hope to return to myself
- r/Mounjaro· u/Far_Employ_4155 · 9d ago
Seems like working now!!
Seems like working now!!
- r/Mounjaro· u/UmmmW1 · 9d ago
The stall has ended!
The stall has ended!
- r/Mounjaro· u/delicatechaos0 · 9d ago
Is this normal?
Is this normal?
- r/Mounjaro· u/InfamousMeringue2417 · 10d ago
Mounjaro changed my face and my life
Mounjaro changed my face and my life
- X· CryptoDaddi@TheCryptoDaddi♥ 9 · 2mo ago
Comparing Ozempic to HGH is fascinating behavior.
- X· Alex Aaron@alexaaronlab♥ 1 · 2mo ago
Ozempic vs Retatrutide
- X· Peptide Critic@PeptideCritic♥ 2 · 2mo ago
How we actually travel with peptides—short flights, long hauls, and everything in between. I break down real-world cold
- X· Kimera Chems@KimeraChems♥ 11 ↻ 1 · 2mo ago
SANA (MVD1): the salicylate derivative that turns fat cells into furnaces Most metabolic compounds in the obesity space
- X· Alex Aaron@alexaaronlab · 2mo ago
ozempic is retrded
- X· Alex Aaron@alexaaronlab♥ 16 ↻ 1 · 2mo ago
People don’t realize what’s about to happen. Ozempic and bpc was just the gateway drug. Over the next 5 years you’ll s
- X· Rahul Modi | Peptide Coach@rahulmodifit♥ 5 · 3mo ago
yes, i made the empire state building meme… don’t use reta if your goal is just to eat less. one of the biggest misco
- X· CryptoDaddi@TheCryptoDaddi♥ 296 ↻ 32 · 3mo ago
Here’s a quick reference guide to almost all of the popular peptides within the researcher/biohacking sphere: REPAIR, R
- X· BowTiedPep@BowTiedPep♥ 7 · 3mo ago
My wife was using oral Wegovy until she started having horrible chest pain. I told her it was reflux, gave her pepto wit
- X· Biotides@biotides♥ 1 · 3mo ago
Semaglutide has been around since 2017. But here's what most people don't know about its development. It took over 15
- X· Chris G.@golfmusclemstr♥ 1 · 3mo ago
👦 16.1% BMI reduction in adolescents. In the STEP TEENS trial, once-weekly semaglutide 2.4 mg reduced BMI by 16.1% in t
- X· Jesse Morse, M.D.@DrJesseMorseExpert · 2d ago
@longevitymediaa Not with Reta. We haven’t seen the specific muscle loss numbers for Reta, but I suspect it would be su
- X· 𝗥𝗮𝗻𝗱𝘆 𝗖𝗼𝗹𝗲@RegenRandyExpert♥ 4 · 2d ago
@Compound_Cowboi You’re spot on. Ozempic Face Prevention is GHK-Cu.
- X· Endpoints News@endptsExpert · 3d ago
Regeneron's experimental antibody helped patients who stopped Wegovy regain about as much muscle as they had lost on the
- X· Eric Topol@EricTopolExpert♥ 164 ↻ 42 · 3d ago
Direct benefits of semaglutide/GLP-1 on the kidney in patients with Type 2 diabetes and chronic kidney disease, a place
- X· STAT@statnewsExpert ↻ 1 · 5d ago
2/ On its website, Novo no longer labels its treatment, Wegovy, as a "weight management" drug or "anti-obesity" medicine
- X· Eric Topol@EricTopolExpert♥ 68 ↻ 6 · 10d ago
The cardiovascular benefit from Ozempic in the large randomized trial was substantially not related to weight loss https
- X· Endpoints News@endptsExpert♥ 3 · 13d ago
Novo plans at least five multi-blockbuster launches by 2030, CEO Mike Doustdar said, as it looks to diversify beyond sem
- X· David Sinclair@davidasinclairExpert♥ 164 ↻ 7 · 13d ago
A retinal stroke is a serious but very rare apparent risk of semaglutide, about 1 additional case / 10,000 people / year
- X· Healthy Alfred ☄️@HealthyAlfredExpert♥ 1 ↻ 1 · 15d ago
cagrilintide is the only peptide I'd take for fat loss. it's not a GLP-1. it's amylin — the hormone your pancreas relea
No curated experts have Semaglutide tagged in their peptideAreas yet.
No YouTube videos mentioning Semaglutide in our index yet. The YouTube RSS cron pulls every 6 hours.
Community experiences
1 approved · moderatedFirst-hand accounts from readers who've used Semaglutide. These are personal anecdotes, not clinical evidence or medical advice — every post is reviewed before it appears.
- Anneli K··4 min readMember
GHK-Cu + Semaglutide experience — Anneli K
I’m 41 and work as a marketing director. I started semaglutide after gaining 12 kg over about a year and a half during early perimenopause. My vasomotor symptoms started when I was 39, and even though I’d been a competitive runner in my twenties, this was the first time I felt like my body had changed in a way I couldn’t just train or diet my way out of.
The frustrating part was that I was already doing the “right” things. I wasn’t inactive, and I wasn’t eating badly. I was eating a Mediterranean-style diet, lifting heavy three times a week, keeping protein around 1.6 g/kg, and walking at least 8,000 steps most days. That helped me lose about 4 kg at first, but then my weight just stopped moving for six months. Not slowly. Not inconsistently. Just nothing.
Around the same time, my skin started becoming a separate issue. I’d used tretinoin every night for three years, and for a long time it had worked well for me. Then it didn’t. My skin started looking and feeling more fragile, especially around my eyes, and I was getting redness and irritation I hadn’t dealt with in my mid-thirties. I kept telling myself it was just part of using tret, but looking back, I think I had been pushing through it for too long.
I wanted to keep the whole process fairly simple, mostly so I could tell what was actually making a difference. So I didn’t add any “GLP-1 stack” or extra peptides for body composition. I started Wegovy through my family doctor and titrated from 0.25 mg to 0.5 mg, then to 1.0 mg weekly.
The first month was honestly pretty uneventful. I had mild constipation, but no real appetite change and no weight loss. Around week six, on 0.5 mg, the food noise finally switched off. I know that phrase gets repeated constantly, but that really is what it felt like. Food just stopped taking up so much mental space. By week eight, I was down 3 kg.
From weeks nine to sixteen, on 1.0 mg, the weight loss became steadier, although not perfectly linear. I stalled around week twelve, which was annoying, and then lost another 4 kg by week sixteen. The main side effect for me was reflux, especially if I ate too late. Sleeping on a wedge helped, but if I were starting again, I’d be more proactive from the beginning: earlier dinners, electrolytes, and an actual reflux plan instead of figuring it out in real time.
I added a GHK-Cu topical serum around week six and used it morning and night on my face and neck. It was from a cosmeceutical brand, not a compounded product. Around the same time, I cut tretinoin back from every night to three nights a week. By week ten, I had stopped tretinoin completely.
That was probably the biggest surprise of the whole thing. By week fourteen, my skin texture looked better than it ever had on retinoids. The redness had calmed down, my tone looked more even, and I wasn’t dealing with irritation anymore. I wish I’d tried GHK-Cu earlier, but I also think stopping nightly tretinoin gave my skin a chance to recover. “Retinoid fatigue” is the phrase I now use for it, even if that’s not a formal diagnosis. At the time, I just thought I was supposed to keep tolerating it.
By month five, I was down 9 kg and holding steady, with a maintenance plan in place. I do think I may have lost around 1.5 kg of lean mass, but that’s only a guess. If I could go back, I’d get a DXA scan at baseline so I wasn’t trying to estimate it after the fact.
One thing I didn’t expect was how opinionated people would be about a GLP-1 prescription. I’m much more private about it now. Not because I’m ashamed of using it, but because I don’t want every conversation about my health to turn into a debate.
Overall, this has been a very positive experience, but definitely not a magic button. Semaglutide helped me get past a plateau that felt very tied to perimenopause, but the basics still mattered: lifting, protein, walking, sleep, and managing side effects properly. GHK-Cu ended up being important in a different way. Alongside stopping nightly tretinoin, it seemed to help my skin recover from an issue I had been normalizing for way too long.
I also wish there were more honest, specific stories from perimenopausal women using GLP-1s. Most of what I found was either very generic or buried in Reddit threads, and the body composition side of it barely gets discussed. Same with GHK-Cu for people whose skin feels like it has simply had enough of retinoids. In both cases, the most useful information came from other people’s lived experience, not from the usual medical or skincare content.
Community Notes
0 approved · moderated
Structured notes from readers — context, citations, corrections, and first-hand experience. Every note is moderated before it appears. Notes do not replace medical review; they supplement it.
No approved notes yet.
Know something that should be on this page? A citation, clarification, or dispute? Sign in and submit the first note.
Submission interface coming in Phase 2. For now, notes are authored in Studio. See the Community Guidelines for moderation criteria.